Surgical perspective in neoadjuvant chemoimmunotherapy for stage II – III non‐small cell lung cancer-Reference-Cited by-同舟云学术

Surgical perspective in neoadjuvant chemoimmunotherapy for stage II – III non‐small cell lung cancer

Author:

Hong Tao¹²,Sun Teng¹²,Zhang Miao³,Liu Xinlong¹²,Yuan Yanliang¹²,Dolo Ponnie Robertlee⁴,Chen Bi⁵,Zhang Hao¹²^ORCID

Affiliation:

1. Department of Thoracic Surgery Affiliated Hospital of Xuzhou Medical University Xuzhou China

2. Thoracic Surgery Laboratory, The First College of Clinical Medicine Xuzhou Medical University Xuzhou China

3. Department of Thoracic Surgery Xuzhou Central Hospital Xuzhou China

4. Department of Gastrointestinal Surgery Affiliated Hospital of Xuzhou Medical University Xuzhou China

5. Department of Respiratory and Critical Care Medicine Affiliated Hospital of Xuzhou Medical University Xuzhou China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

Reference25 articles.

5. Immune checkpoint inhibitors in lung cancer: role of biomarkers and combination therapies;Maung TZ;Cureus.,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献